95TH GENERAL ASSEMBLY
State of Illinois
2007 and 2008
HB4410


 
Introduced , by Rep. Elizabeth Coulson
 
SYNOPSIS AS INTRODUCED:
 		








  



225 ILCS 85/22
  from Ch. 111, par. 4142



225 ILCS 85/22c new










    Amends the Pharmacy Practice Act. Provides that prior to dispensing a prescription, a pharmacist must present the patient or a person legally authorized to make decisions for  the patient with the option of having the symptom or purpose for the medication disclosed on the prescription label, and that if the patient or person legally authorized to make decisions for  the patient chooses to have the symptom or purpose for the medication   disclosed on the label, the pharmacist must specify the symptom or purpose of the medication in the prescription order and the prescription label must contain that symptom or purpose.
















LRB095 16588 RAS 42619 b

















FISCAL NOTE ACT MAY APPLY
















 


 


A BILL FOR









 











HB4410

LRB095 16588 RAS 42619 b






1
    AN ACT concerning regulation.

 
2
    Be it enacted by the People of the State of Illinois,
 
3
represented in the General Assembly:


 
4
    Section 5. The Pharmacy Practice Act is amended  by changing 
5
Section 22 and  by adding Section 22c as follows:
 



6
    (225 ILCS 85/22)  (from Ch. 111, par. 4142)


7
    (Section scheduled to be repealed on January 1, 2018)

8
    Sec. 22. Except only in the case of a drug, medicine or 
9
poison
which is lawfully sold or dispensed, at retail, in the 
10
original and
unbroken package of the manufacturer, packer, or 
11
distributor thereof,
and which package bears the original label 
12
thereon showing the name
and address of the manufacturer, 
13
packer, or distributor thereof, and
the name of the drug, 
14
medicine, or poison therein contained, and the
directions for 
15
its use, no person shall sell or dispense, at retail,
any drug, 
16
medicine, or poison, without affixing to the box, bottle,

17
vessel, or package containing the same, a label bearing the 
18
name of
the article distinctly shown, and the directions for 
19
its use, with
the name and address of the pharmacy wherein the 
20
same is sold or dispensed.
However, in the case of a drug, 
21
medicine, or poison which is sold or
dispensed pursuant to a 
22
prescription of a physician licensed to practice
medicine in 
23
all of its branches, licensed dentist, licensed veterinarian,

 


 






HB4410
- 2 -
LRB095 16588 RAS 42619 b




1
licensed podiatrist, or therapeutically or diagnostically 
2
certified
optometrist authorized by law to prescribe drugs or 
3
medicines or poisons,
the label affixed to the box, bottle, 
4
vessel, or package containing the
same shall show: (a) the name 
5
and address of the pharmacy
wherein the same is sold or 
6
dispensed; (b) the name or initials of
the person, authorized 
7
to practice pharmacy under the provisions of
this Act, selling 
8
or dispensing the same, (c) the date on which such
prescription 
9
was filled; (d) the name of the patient; (e) the serial
number 
10
of such prescription as filed in the prescription files; (f)

11
the last name of the practitioner who prescribed such 
12
prescriptions;
(g) the directions for use thereof as contained 
13
in such prescription;
and (h) the proprietary name or names or 
14
the established name or
names of the drugs, the dosage and 
15
quantity, except as otherwise authorized
by regulation of the 
16
Department; and (i) the symptom or purpose for which the drug 
17
is being prescribed if the prescription order specifies the 
18
symptom or purpose as provided for under Section 22c of this 
19
Act.


20
(Source: P.A. 95-689, eff. 10-29-07.)

 
21
    (225 ILCS 85/22c new)

22
    Sec. 22c. Statement of symptom or purpose on prescription 
23
label.
24
    (a) The General Assembly finds that by authorizing 
25
pharmacists to print the symptom or purpose of medications on 
 


 






HB4410
- 3 -
LRB095 16588 RAS 42619 b




1
prescription labels, possible medication errors may be 
2
avoided.
3
    (b) Prior to dispensing a prescription, a pharmacist must 
4
present the patient or a person legally authorized to make 
5
decisions for  the patient with the option of having the symptom 
6
or purpose for the medication disclosed on the prescription 
7
label. If the patient or person legally authorized to make 
8
decisions for  the patient chooses to have the symptom or 
9
purpose for the medication   disclosed on the label, the 
10
pharmacist must specify the symptom or purpose of the 
11
medication in the prescription order.